Literature DB >> 1842880

Evoked otoacoustic emissions from ears with idiopathic sudden deafness.

T Sakashita1, Y Minowa, K Hachikawa, T Kubo, Y Nakai.   

Abstract

Evoked otoacoustic emissions (EOEs) were examined in ears with idiopathic sudden deafness (ISD) at an early stage after onset and were compared with those in ears with long-standing sensorineural hearing losses of unknown etiology (SHLUE). In ears with SHLUE, EOEs were not recordable from ears with a hearing loss exceeding 35 dB at minimum hearing level of 4 audiometric frequencies: 500, 1,000, 2,000 and 4,000 Hz (4 MHL). On the other hand, although 4 MHLs were greater than 35 dB in most of the ears, EOEs could be detected in about one-half of the ears with ISD, and, moreover, the majority of these EOE detectable ears showed a good hearing prognosis in spite of the degree of hearing loss. There was, however, no correlation between EOE threshold and degree of hearing recovery. From these results it seems that EOE testing might be clinically applicable for predicting whether or not hearing loss due to ISD can be recovered.

Entities:  

Mesh:

Year:  1991        PMID: 1842880     DOI: 10.3109/00016489109134984

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

1.  The prognostic value of the otoacoustic emission test in low frequency sudden hearing loss.

Authors:  Andrea Canale; Michelangelo Lacilla; Carlo Giordano; Alice De Sanctis; Roberto Albera
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-02       Impact factor: 2.503

2.  Assessment of the influence of whole body vibration on Cochlear function.

Authors:  Seyyed-Ali Moussavi-Najarkola; Ali Khavanin; Ramazan Mirzaei; Mojdeh Salehnia; Mehdi Akbari
Journal:  J Occup Med Toxicol       Date:  2012-06-21       Impact factor: 2.646

Review 3.  Vestibular evoked myogenic potentials in the prognosis of sudden hearing loss ‒ a systematic review.

Authors:  Nathalia de Paula Doyle Maia; Karen de Carvalho Lopes; Fernando Freitas Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2019-11-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.